Federal Register Notice: FDA is making available a draft guidance for industry and review staff, Target Product Profile — A Strategic Development Process Tool. The guidance intends to inform sponsors and CDER review staff of the potential usefulness of a target product profile, which can be prepared by a sponsor and then shared voluntarily with the appropriate FDA review staff to facilitate communication on a particular drug development program. To download this guidance, click here. To view this notice, click here.